Literature DB >> 30365040

Suppressing serum response factor inhibits invasion in cervical cancer cell lines via regulating Egr‑1 and epithelial-mesenchymal transition.

Liya Ma1, Ying Yu2, Xiaohui Qu3.   

Abstract

Serum response factor (SRF) is a transcription factor that has important roles in tumor progression. However, its role in cervical cancer cell proliferation and invasion remains unclear. The present study revealed that SRF silencing constrained cervical cancer cell proliferation and invasion via controlling early growth response‑1 (Egr‑1). The results demonstrated that SRF was significantly increased in cervical cancer tissues and cell lines, compared with normal. Suppressing SRF, by using a loss‑of‑function experiment, constrained cervical cancer cell proliferation, invasion, and epithelial‑mesenchymal transition. Furthermore, SRF knockdown significantly downregulated Egr‑1 expression in cervical cancer cell lines, and overexpression of Egr‑1 reversed the effect of SRF on cell proliferation, invasion, and epithelial‑mesenchymal transition. Therefore, SRF may control cell proliferation and invasion by regulating Egr‑1 in cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30365040     DOI: 10.3892/ijmm.2018.3954

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  3 in total

1.  Inhibition of ANXA2 regulated by SRF attenuates the development of severe acute pancreatitis by inhibiting the NF-κB signaling pathway.

Authors:  Guanxiu Tang; Can Yu; Kaimin Xiang; Min Gao; Zuoliang Liu; Bingchang Yang; Mingshi Yang; Shangping Zhao
Journal:  Inflamm Res       Date:  2022-07-28       Impact factor: 6.986

2.  EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.

Authors:  Juanhong Zhao; Haixia Li; Miao Yuan
Journal:  Genes Genomics       Date:  2021-03-09       Impact factor: 1.839

3.  Clinical Significance and Potential Regulatory Mechanisms of Serum Response Factor in 1118 Cases of Thyroid Cancer Based on Gene Chip and RNA-Sequencing Data.

Authors:  Qiang-Bin Jing; Hai-Xiao Tong; Wei-Jian Tang; Shao-Dong Tian
Journal:  Med Sci Monit       Date:  2020-01-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.